A self-assembled pH/enzyme dual-responsive prodrug with PEG deshielding for multidrug-resistant tumor therapy

Autor: Yun Chen, Zhiyuan Xu, Ronghua Ni, Jianhua Zhu
Rok vydání: 2020
Předmět:
Surface Properties
Biomedical Engineering
Mice
Nude

ATP-binding cassette transporter
02 engineering and technology
010402 general chemistry
Endocytosis
01 natural sciences
Polyethylene Glycols
Rats
Sprague-Dawley

Mice
In vivo
Cell Line
Tumor

PEG ratio
Animals
Humans
General Materials Science
Prodrugs
Particle Size
Cell Proliferation
Antibiotics
Antineoplastic

Molecular Structure
Chemistry
Mammary Neoplasms
Experimental

General Chemistry
General Medicine
Prodrug
Hydrogen-Ion Concentration
021001 nanoscience & nanotechnology
Drug Resistance
Multiple

0104 chemical sciences
Rats
Multiple drug resistance
Drug Liberation
Doxorubicin
Drug Resistance
Neoplasm

Cancer research
PEGylation
MCF-7 Cells
Matrix Metalloproteinase 2
Nanoparticles
ATP-Binding Cassette Transporters
Efflux
Drug Screening Assays
Antitumor

0210 nano-technology
Peptides
Zdroj: Journal of materials chemistry. B. 8(6)
ISSN: 2050-7518
Popis: Multidrug resistance (MDR) is one of the major obstacles for tumor therapy. Intake by receptor-mediated endocytosis enables molecules to bypass ABC transporter efflux, which is the primary mechanism of MDR. Here, we developed a novel pH/enzyme dual-responsive polypeptide prodrug to reverse multidrug resistance. This drug is composed of pH/MMP2-sensitive nanoparticles (MSNPs) self-assembled from mPEG–peptide–DOX. MSNPs can overcome sequential physiological barriers of multidrug resistance by prolonging the circulation time through PEGylation, enhancing tumor accumulation through passive targeting, increasing tumor penetration by enzyme-sensitive PEG deshielding, bypassing ABC transporter efflux by undergoing receptor-mediated endocytosis, and inducing sufficient DOX release from nanoparticles triggered by lysosomal pH. The reversal of MDR by MSNPs was evaluated in MCF-7/ADR cells and nude mice bearing tumors consisting of MCF-7/ADR cells. Both in vitro and in vivo studies showed that the MSNPs can effectively reverse MDR. Thus, MSNPs may constitute a potentially promising strategy for overcoming MDR in clinical applications.
Databáze: OpenAIRE